DeutschNewstral
Article
Haaretz on 2015-10-01 17:01
Teva Pharm to buy Mexican drug firm Rimsa for $2.3 billion
Related news
- NTeva to Buy Mexico’s Rimsa for About $2.3 Billionnysepost.com
Teva buys Mexican pharmaceutical company Rimsa for $2.3 billionThe Jerusalem Post (JPost.com)- MTeva to acquire Mexico’s Rimsa for $2.3 billionmarketwatch.com
- Teva Pharm Nudges Up Earnings Forecast, Names New CFOHaaretz
Teva Pharm Q1 profit slips but Austedo sales keep risingreuters.com- Israel’s Teva Pharm Q1 profit falls slightly less than forecastreuters.com
- Israel’s Teva Pharm profit falls less than expectedreuters.com
Berkshire's 4th Quarter Buy Teva Appears Cheap And TroubledForbes
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bidReuters
Teva to buy Allergan generic drug business for $40.5-billion, drops Mylan bidThe Globe and Mail- EArby's parent company to buy burger chain Sonic in $2.3 billion dealeu.usatoday.com
- Teva Pharm Q4 profit tops estimates by one centreuters.com
- Teva Pharm second-quarter profit slightly beats profit forecastreuters.com
Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bidbusiness.financialpost.com- Teva Pharm raises 2018 profit outlook after third-quarter tops estimatesreuters.com
- Israel's Teva Pharm in talks to co-produce COVID-19 vaccinesThe Jerusalem Post (JPost.com)
- ITeva Pharm Q3 profit in line with forecasts, tweaks 2020 outlookin.reuters.com
- Video: Teva buys Allergan for $40.5-billionThe Globe and Mail
- Report
Teva buys Allergan for $40.5 billionReuters
- Teva Pharm fourth quarter profit tops estimates, sees mostly flat 2021reuters.com